Joseph McMahon, President and CEO of KBI Biopharma notes, "We recognize the significant market interest in and adoption of this technology and are very pleased to now offer cell line generation using the PER.
基于1个网页-相关网页
joseph mcmahon
约瑟夫·麦克马洪
以上为机器翻译结果，长、整句建议使用 人工翻译 。
应用推荐
模块上移
模块下移
不移动